Literature DB >> 1704282

Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes.

H G Schaible1, B Jarrott, P J Hope, A W Duggan.   

Abstract

In anaesthetized spinal cats, the release of immunoreactive substance P in the spinal cord during development of an acute inflammation in one knee joint was studied with antibody microprobes. The microprobes bore antibodies directed to the C- or N-terminus of substance P. With the normal knee joint, innocuous mechanical stimuli (flexion, pressure) did not result in spinal release of immunoreactive substance P. Following injection of kaolin and carrageenan into a knee, evidence for release of substance P following joint stimulation was found in 7 of 10 cats. Such release did not occur for several hours after joint injection and was detected predominantly in the superficial dorsal horn, the dorsal columns and at the dorsal surface of the spinal cord. In some experiments release was detected in the deep dorsal horn and upper ventral horn. Release of immunoreactive substance P required periods of mechanical stimulation such as flexion of, or pressure to, the inflamed joint. The failure to detect central release of substance P from stimulation of normal joints, and the release of substance P, after a delay, from inflamed joints, suggest that the fibres releasing this compound require sensitization by inflammatory mediators before they are excited by joint stimuli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704282     DOI: 10.1016/0006-8993(90)90830-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

1.  Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P.

Authors:  W Kessler; C Kirchhoff; P W Reeh; H O Handwerker
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation.

Authors:  C Abbadie; J Trafton; H Liu; P W Mantyh; A I Basbaum
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

4.  Analgesic doses of morphine do not reduce noxious stimulus-evoked release of immunoreactive neurokinins in the dorsal horn of the spinal cat.

Authors:  C W Lang; A W Duggan; P J Hope
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

5.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

6.  Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

7.  Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo.

Authors:  B J Allen; S D Rogers; J R Ghilardi; P M Menning; M A Kuskowski; A I Basbaum; D A Simone; P W Mantyh
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

8.  Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat.

Authors:  L F Donaldson; D S McQueen; J R Seckl
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

9.  Ethanol inhibits the binding of substance P to rat brain cortex NK1 receptors.

Authors:  S Scarrone; A Cappelli; A Cupello; M Matarrese; R M Moresco; F Fazio
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

10.  Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats.

Authors:  Lisa M Thomson; Gregory W Terman; Jinsong Zeng; Janet Lowe; Charles Chavkin; Sam M Hermes; Deborah M Hegarty; Sue A Aicher
Journal:  J Pain       Date:  2007-10-24       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.